December 8 at 2:45 pm SGT

COVID-19 has undoubtedly accelerated the development and adoption of a wide range of health technologies, from teleconsultations to cloud-based health records to health information apps. However, the backlog of missed consultations and delayed diagnoses for non-infectious and elective procedures portends a second health crisis even after the current pandemic is beaten back. This presents numerous opportunities to further the positive momentum in health digitalization, starting with capital deployment. What's the outlook for the health tech investment environment in the Asia Pacific? Which areas of digital health are poised for rapid growth? Are financial markets well-structured to catalyze the future of health and care?

Speakers

Fidah Alsagoff
Senior Managing Director, Joint Head, Enterprise Development Group; Head, Life Sciences, Temasek

Marco Huesch
Managing Director and Chief Medical Officer, Ping An Global Voyager Fund

Ganen Sarvananthan
Co-Managing Partner, TPG Capital Asia

Chris Ting
Founder and Group CEO, Pathology Asia
 

Moderator

Roberta Lipson
CEO, New Frontier Health; Founder and CEO, United Family Healthcare